Amicus Therapeutics (FOLD) News Today $7.65 +0.01 (+0.13%) Closing price 04:00 PM EasternExtended Trading$7.62 -0.04 (-0.46%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FOLD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Jump Financial LLC Has $3.31 Million Holdings in Amicus Therapeutics, Inc. $FOLDAugust 28 at 6:15 AM | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by AnalystsAugust 28 at 2:25 AM | americanbankingnews.comAmicus Therapeutics, Inc. $FOLD Holdings Lifted by Capital Fund Management S.A.August 27 at 4:49 AM | marketbeat.comMultiple Jewish Organizations File Second Circuit Amicus Brief in Support of Previously Detained Tufts StudentAugust 25 at 4:22 PM | businesswire.comCharles Schwab Investment Management Inc. Sells 95,723 Shares of Amicus Therapeutics, Inc. $FOLDAugust 24, 2025 | marketbeat.comAmicus Therapeutics, Inc. $FOLD Position Cut by Fox Run Management L.L.C.August 23, 2025 | marketbeat.comAmicus Therapeutics, Inc. $FOLD Shares Bought by Invesco Ltd.August 23, 2025 | marketbeat.com824,740 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Osterweis Capital Management Inc.August 22, 2025 | marketbeat.comWellington Management Group LLP Boosts Stake in Amicus Therapeutics, Inc. $FOLDAugust 22, 2025 | marketbeat.comIn NCLA Amicus Win, NY State Supreme Court, Appellate Div., Scraps Illegal Fine Against TrumpAugust 21, 2025 | globenewswire.comAberdeen Group plc Acquires 205,834 Shares of Amicus Therapeutics, Inc. $FOLDAugust 21, 2025 | marketbeat.comAmicus Therapeutics, Inc. $FOLD Stock Position Increased by Algert Global LLCAugust 20, 2025 | marketbeat.comVanguard Group Inc. Sells 208,342 Shares of Amicus Therapeutics, Inc. $FOLDAugust 20, 2025 | marketbeat.comNuveen LLC Makes New $28.74 Million Investment in Amicus Therapeutics, Inc. $FOLDAugust 19, 2025 | marketbeat.comThe Association of American Physicians and Surgeons Filed an Amicus Brief in the Ninth Circuit in Support of Restoring California's Religious Exemption to VaccinationAugust 18, 2025 | globenewswire.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Stake Boosted by Deutsche Bank AGAugust 17, 2025 | marketbeat.comEntropy Technologies LP Acquires Shares of 38,790 Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 16, 2025 | marketbeat.comAmicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-ChangerAugust 14, 2025 | tipranks.comConnor Clark & Lunn Investment Management Ltd. Buys 483,698 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 14, 2025 | marketbeat.comAmicus Therapeutics (NASDAQ:FOLD) Trading 9.3% Higher - Here's WhyAugust 5, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Just Released Its Second-Quarter Earnings: Here's What Analysts ThinkAugust 4, 2025 | finance.yahoo.com187,897 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Jefferies Financial Group Inc.August 4, 2025 | marketbeat.comXTX Topco Ltd Has $871,000 Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 4, 2025 | marketbeat.comAssetmark Inc. Trims Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 4, 2025 | marketbeat.comAmicus Therapeutics Inc (FOLD) Q2 2025 Earnings Call Highlights: Sustained Revenue Growth ...August 3, 2025 | gurufocus.comQ2 2025 Amicus Therapeutics Inc Earnings Call TranscriptAugust 3, 2025 | gurufocus.comAmicus Therapeutics (NASDAQ:FOLD) Upgraded to Buy at Wall Street ZenAugust 3, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from BrokeragesAugust 3, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | msn.comAmicus (FOLD) Q2 Revenue Jumps 22%August 1, 2025 | fool.comAmicus Therapeutics: Going Beyond $1B Target Revenues Of Lead Products With Licensed DMX-200August 1, 2025 | seekingalpha.comBank of America Securities Remains Bullish on Amicus Therapeutics (FOLD) With a $13 PTAugust 1, 2025 | insidermonkey.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $1.74 Million Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 1, 2025 | marketbeat.comY Intercept Hong Kong Ltd Trims Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 1, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $1.52 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)August 1, 2025 | marketbeat.comAmicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate UpdatesJuly 31, 2025 | globenewswire.comVictory Capital Management Inc. Boosts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)July 29, 2025 | marketbeat.comIn NCLA Amicus Win, Eleventh Circuit Vacates SEC Order Used to Fund Its Illegal Collection of DataJuly 28, 2025 | globenewswire.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Legato Capital Management LLCJuly 26, 2025 | marketbeat.comMorgan Stanley Upgrades Amicus (FOLD) on IP Strength and Pipeline ExpansionJuly 25, 2025 | msn.comDimerix Secures Major Licensing Deal with Amicus TherapeuticsJuly 24, 2025 | tipranks.comAmicus Therapeutics (FOLD) Expected to Announce Earnings on ThursdayJuly 24, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by New York State Common Retirement FundJuly 24, 2025 | marketbeat.comAmicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025July 21, 2025 | globenewswire.com58,396 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Purchased by Edgestream Partners L.P.July 20, 2025 | marketbeat.comAmicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switchingJuly 18, 2025 | msn.comAmicus Therapeutics (NASDAQ:FOLD) Shares Gap Up - Here's WhyJuly 17, 2025 | marketbeat.comAmicus Therapeutics (NASDAQ:FOLD) Upgraded at Morgan StanleyJuly 17, 2025 | marketbeat.comAmicus (FOLD) Gets Japan Approval for Pombiliti + OpfoldaJuly 16, 2025 | finance.yahoo.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by Rice Hall James & Associates LLCJuly 14, 2025 | marketbeat.com Get Amicus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FOLD Media Mentions By Week FOLD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FOLD News Sentiment▼1.410.99▲Average Medical News Sentiment FOLD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FOLD Articles This Week▼116▲FOLD Articles Average Week Get the Latest News and Ratings for FOLD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Amicus Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MDGL News EXAS News HALO News RGEN News IONS News ALKS News LGND News BCRX News CLDX News NVAX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FOLD) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amicus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amicus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access